Global Functional Dyspepsia Drug Market Insights and Forecast to 2028

Report ID: 1226995 | Published Date: Jan 2025 | No. of Page: 112 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Functional Dyspepsia Drug Product Introduction
    1.2 Market by Type
        1.2.1 Global Functional Dyspepsia Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Prokinetic Drugs
        1.2.3 Gastric Antisecretory Drugs
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Functional Dyspepsia Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Drugstores
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Functional Dyspepsia Drug Sales Estimates and Forecasts 2017-2028
    2.2 Global Functional Dyspepsia Drug Revenue Estimates and Forecasts 2017-2028
    2.3 Global Functional Dyspepsia Drug Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Functional Dyspepsia Drug Sales by Region
        2.4.1 Global Functional Dyspepsia Drug Sales by Region (2017-2022)
        2.4.2 Global Sales Functional Dyspepsia Drug by Region (2023-2028)
    2.5 Global Functional Dyspepsia Drug Revenue by Region
        2.5.1 Global Functional Dyspepsia Drug Revenue by Region (2017-2022)
        2.5.2 Global Functional Dyspepsia Drug Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Functional Dyspepsia Drug Sales by Manufacturers
        3.1.1 Global Top Functional Dyspepsia Drug Manufacturers by Sales (2017-2022)
        3.1.2 Global Functional Dyspepsia Drug Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Functional Dyspepsia Drug in 2021
    3.2 Global Functional Dyspepsia Drug Revenue by Manufacturers
        3.2.1 Global Functional Dyspepsia Drug Revenue by Manufacturers (2017-2022)
        3.2.2 Global Functional Dyspepsia Drug Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Functional Dyspepsia Drug Revenue in 2021
    3.3 Global Functional Dyspepsia Drug Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Functional Dyspepsia Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Functional Dyspepsia Drug Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Functional Dyspepsia Drug Sales by Type
        4.1.1 Global Functional Dyspepsia Drug Historical Sales by Type (2017-2022)
        4.1.2 Global Functional Dyspepsia Drug Forecasted Sales by Type (2023-2028)
        4.1.3 Global Functional Dyspepsia Drug Sales Market Share by Type (2017-2028)
    4.2 Global Functional Dyspepsia Drug Revenue by Type
        4.2.1 Global Functional Dyspepsia Drug Historical Revenue by Type (2017-2022)
        4.2.2 Global Functional Dyspepsia Drug Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Functional Dyspepsia Drug Revenue Market Share by Type (2017-2028)
    4.3 Global Functional Dyspepsia Drug Price by Type
        4.3.1 Global Functional Dyspepsia Drug Price by Type (2017-2022)
        4.3.2 Global Functional Dyspepsia Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Functional Dyspepsia Drug Sales by Application
        5.1.1 Global Functional Dyspepsia Drug Historical Sales by Application (2017-2022)
        5.1.2 Global Functional Dyspepsia Drug Forecasted Sales by Application (2023-2028)
        5.1.3 Global Functional Dyspepsia Drug Sales Market Share by Application (2017-2028)
    5.2 Global Functional Dyspepsia Drug Revenue by Application
        5.2.1 Global Functional Dyspepsia Drug Historical Revenue by Application (2017-2022)
        5.2.2 Global Functional Dyspepsia Drug Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Functional Dyspepsia Drug Revenue Market Share by Application (2017-2028)
    5.3 Global Functional Dyspepsia Drug Price by Application
        5.3.1 Global Functional Dyspepsia Drug Price by Application (2017-2022)
        5.3.2 Global Functional Dyspepsia Drug Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Functional Dyspepsia Drug Market Size by Type
        6.1.1 North America Functional Dyspepsia Drug Sales by Type (2017-2028)
        6.1.2 North America Functional Dyspepsia Drug Revenue by Type (2017-2028)
    6.2 North America Functional Dyspepsia Drug Market Size by Application
        6.2.1 North America Functional Dyspepsia Drug Sales by Application (2017-2028)
        6.2.2 North America Functional Dyspepsia Drug Revenue by Application (2017-2028)
    6.3 North America Functional Dyspepsia Drug Market Size by Country
        6.3.1 North America Functional Dyspepsia Drug Sales by Country (2017-2028)
        6.3.2 North America Functional Dyspepsia Drug Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Functional Dyspepsia Drug Market Size by Type
        7.1.1 Europe Functional Dyspepsia Drug Sales by Type (2017-2028)
        7.1.2 Europe Functional Dyspepsia Drug Revenue by Type (2017-2028)
    7.2 Europe Functional Dyspepsia Drug Market Size by Application
        7.2.1 Europe Functional Dyspepsia Drug Sales by Application (2017-2028)
        7.2.2 Europe Functional Dyspepsia Drug Revenue by Application (2017-2028)
    7.3 Europe Functional Dyspepsia Drug Market Size by Country
        7.3.1 Europe Functional Dyspepsia Drug Sales by Country (2017-2028)
        7.3.2 Europe Functional Dyspepsia Drug Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Functional Dyspepsia Drug Market Size by Type
        8.1.1 Asia Pacific Functional Dyspepsia Drug Sales by Type (2017-2028)
        8.1.2 Asia Pacific Functional Dyspepsia Drug Revenue by Type (2017-2028)
    8.2 Asia Pacific Functional Dyspepsia Drug Market Size by Application
        8.2.1 Asia Pacific Functional Dyspepsia Drug Sales by Application (2017-2028)
        8.2.2 Asia Pacific Functional Dyspepsia Drug Revenue by Application (2017-2028)
    8.3 Asia Pacific Functional Dyspepsia Drug Market Size by Region
        8.3.1 Asia Pacific Functional Dyspepsia Drug Sales by Region (2017-2028)
        8.3.2 Asia Pacific Functional Dyspepsia Drug Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Functional Dyspepsia Drug Market Size by Type
        9.1.1 Latin America Functional Dyspepsia Drug Sales by Type (2017-2028)
        9.1.2 Latin America Functional Dyspepsia Drug Revenue by Type (2017-2028)
    9.2 Latin America Functional Dyspepsia Drug Market Size by Application
        9.2.1 Latin America Functional Dyspepsia Drug Sales by Application (2017-2028)
        9.2.2 Latin America Functional Dyspepsia Drug Revenue by Application (2017-2028)
    9.3 Latin America Functional Dyspepsia Drug Market Size by Country
        9.3.1 Latin America Functional Dyspepsia Drug Sales by Country (2017-2028)
        9.3.2 Latin America Functional Dyspepsia Drug Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Functional Dyspepsia Drug Market Size by Type
        10.1.1 Middle East and Africa Functional Dyspepsia Drug Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Functional Dyspepsia Drug Revenue by Type (2017-2028)
    10.2 Middle East and Africa Functional Dyspepsia Drug Market Size by Application
        10.2.1 Middle East and Africa Functional Dyspepsia Drug Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Functional Dyspepsia Drug Revenue by Application (2017-2028)
    10.3 Middle East and Africa Functional Dyspepsia Drug Market Size by Country
        10.3.1 Middle East and Africa Functional Dyspepsia Drug Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Functional Dyspepsia Drug Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Bayer
        11.1.1 Bayer Corporation Information
        11.1.2 Bayer Overview
        11.1.3 Bayer Functional Dyspepsia Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Bayer Functional Dyspepsia Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Bayer Recent Developments
    11.2 Sumitomo
        11.2.1 Sumitomo Corporation Information
        11.2.2 Sumitomo Overview
        11.2.3 Sumitomo Functional Dyspepsia Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Sumitomo Functional Dyspepsia Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Sumitomo Recent Developments
    11.3 Cadila Pharmaceuticals
        11.3.1 Cadila Pharmaceuticals Corporation Information
        11.3.2 Cadila Pharmaceuticals Overview
        11.3.3 Cadila Pharmaceuticals Functional Dyspepsia Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Cadila Pharmaceuticals Functional Dyspepsia Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Cadila Pharmaceuticals Recent Developments
    11.4 Teva
        11.4.1 Teva Corporation Information
        11.4.2 Teva Overview
        11.4.3 Teva Functional Dyspepsia Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Teva Functional Dyspepsia Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Teva Recent Developments
    11.5 Johnson & Johnson
        11.5.1 Johnson & Johnson Corporation Information
        11.5.2 Johnson & Johnson Overview
        11.5.3 Johnson & Johnson Functional Dyspepsia Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Johnson & Johnson Functional Dyspepsia Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Johnson & Johnson Recent Developments
    11.6 Pfizer
        11.6.1 Pfizer Corporation Information
        11.6.2 Pfizer Overview
        11.6.3 Pfizer Functional Dyspepsia Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Pfizer Functional Dyspepsia Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Pfizer Recent Developments
    11.7 Sanofi
        11.7.1 Sanofi Corporation Information
        11.7.2 Sanofi Overview
        11.7.3 Sanofi Functional Dyspepsia Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Sanofi Functional Dyspepsia Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Sanofi Recent Developments
    11.8 AstraZeneca
        11.8.1 AstraZeneca Corporation Information
        11.8.2 AstraZeneca Overview
        11.8.3 AstraZeneca Functional Dyspepsia Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 AstraZeneca Functional Dyspepsia Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 AstraZeneca Recent Developments
    11.9 Jiangsu Aosaikang Pharma
        11.9.1 Jiangsu Aosaikang Pharma Corporation Information
        11.9.2 Jiangsu Aosaikang Pharma Overview
        11.9.3 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Jiangsu Aosaikang Pharma Recent Developments
    11.10 Eisai
        11.10.1 Eisai Corporation Information
        11.10.2 Eisai Overview
        11.10.3 Eisai Functional Dyspepsia Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Eisai Functional Dyspepsia Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Eisai Recent Developments
    11.11 Kyowa Kirin Pharmaceuticals
        11.11.1 Kyowa Kirin Pharmaceuticals Corporation Information
        11.11.2 Kyowa Kirin Pharmaceuticals Overview
        11.11.3 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Kyowa Kirin Pharmaceuticals Recent Developments
    11.12 Hanmi Pharm
        11.12.1 Hanmi Pharm Corporation Information
        11.12.2 Hanmi Pharm Overview
        11.12.3 Hanmi Pharm Functional Dyspepsia Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Hanmi Pharm Functional Dyspepsia Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Hanmi Pharm Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Functional Dyspepsia Drug Industry Chain Analysis
    12.2 Functional Dyspepsia Drug Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Functional Dyspepsia Drug Production Mode & Process
    12.4 Functional Dyspepsia Drug Sales and Marketing
        12.4.1 Functional Dyspepsia Drug Sales Channels
        12.4.2 Functional Dyspepsia Drug Distributors
    12.5 Functional Dyspepsia Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Functional Dyspepsia Drug Industry Trends
    13.2 Functional Dyspepsia Drug Market Drivers
    13.3 Functional Dyspepsia Drug Market Challenges
    13.4 Functional Dyspepsia Drug Market Restraints
14 Key Findings in The Global Functional Dyspepsia Drug Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Functional Dyspepsia Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Prokinetic Drugs
    Table 3. Major Manufacturers of Gastric Antisecretory Drugs
    Table 4. Major Manufacturers of Others
    Table 5. Global Functional Dyspepsia Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Functional Dyspepsia Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Functional Dyspepsia Drug Sales by Region (2017-2022) & (M Units)
    Table 8. Global Functional Dyspepsia Drug Sales Market Share by Region (2017-2022)
    Table 9. Global Functional Dyspepsia Drug Sales by Region (2023-2028) & (M Units)
    Table 10. Global Functional Dyspepsia Drug Sales Market Share by Region (2023-2028)
    Table 11. Global Functional Dyspepsia Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Functional Dyspepsia Drug Revenue Market Share by Region (2017-2022)
    Table 13. Global Functional Dyspepsia Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Functional Dyspepsia Drug Revenue Market Share by Region (2023-2028)
    Table 15. Global Functional Dyspepsia Drug Sales by Manufacturers (2017-2022) & (M Units)
    Table 16. Global Functional Dyspepsia Drug Sales Share by Manufacturers (2017-2022)
    Table 17. Global Functional Dyspepsia Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Functional Dyspepsia Drug Revenue Share by Manufacturers (2017-2022)
    Table 19. Functional Dyspepsia Drug Price by Manufacturers (2017-2022) &(US$/Unit)
    Table 20. Global Functional Dyspepsia Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Functional Dyspepsia Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Functional Dyspepsia Drug as of 2021)
    Table 22. Functional Dyspepsia Drug Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Functional Dyspepsia Drug Product Offered
    Table 24. Date of Manufacturers Enter into Functional Dyspepsia Drug Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Functional Dyspepsia Drug Sales by Type (2017-2022) & (M Units)
    Table 27. Global Functional Dyspepsia Drug Sales by Type (2023-2028) & (M Units)
    Table 28. Global Functional Dyspepsia Drug Sales Share by Type (2017-2022)
    Table 29. Global Functional Dyspepsia Drug Sales Share by Type (2023-2028)
    Table 30. Global Functional Dyspepsia Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Functional Dyspepsia Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Functional Dyspepsia Drug Revenue Share by Type (2017-2022)
    Table 33. Global Functional Dyspepsia Drug Revenue Share by Type (2023-2028)
    Table 34. Functional Dyspepsia Drug Price by Type (2017-2022) & (US$/Unit)
    Table 35. Global Functional Dyspepsia Drug Price Forecast by Type (2023-2028) & (US$/Unit)
    Table 36. Global Functional Dyspepsia Drug Sales by Application (2017-2022) & (M Units)
    Table 37. Global Functional Dyspepsia Drug Sales by Application (2023-2028) & (M Units)
    Table 38. Global Functional Dyspepsia Drug Sales Share by Application (2017-2022)
    Table 39. Global Functional Dyspepsia Drug Sales Share by Application (2023-2028)
    Table 40. Global Functional Dyspepsia Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Functional Dyspepsia Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Functional Dyspepsia Drug Revenue Share by Application (2017-2022)
    Table 43. Global Functional Dyspepsia Drug Revenue Share by Application (2023-2028)
    Table 44. Functional Dyspepsia Drug Price by Application (2017-2022) & (US$/Unit)
    Table 45. Global Functional Dyspepsia Drug Price Forecast by Application (2023-2028) & (US$/Unit)
    Table 46. North America Functional Dyspepsia Drug Sales by Type (2017-2022) & (M Units)
    Table 47. North America Functional Dyspepsia Drug Sales by Type (2023-2028) & (M Units)
    Table 48. North America Functional Dyspepsia Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Functional Dyspepsia Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Functional Dyspepsia Drug Sales by Application (2017-2022) & (M Units)
    Table 51. North America Functional Dyspepsia Drug Sales by Application (2023-2028) & (M Units)
    Table 52. North America Functional Dyspepsia Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Functional Dyspepsia Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Functional Dyspepsia Drug Sales by Country (2017-2022) & (M Units)
    Table 55. North America Functional Dyspepsia Drug Sales by Country (2023-2028) & (M Units)
    Table 56. North America Functional Dyspepsia Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Functional Dyspepsia Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Functional Dyspepsia Drug Sales by Type (2017-2022) & (M Units)
    Table 59. Europe Functional Dyspepsia Drug Sales by Type (2023-2028) & (M Units)
    Table 60. Europe Functional Dyspepsia Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Functional Dyspepsia Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Functional Dyspepsia Drug Sales by Application (2017-2022) & (M Units)
    Table 63. Europe Functional Dyspepsia Drug Sales by Application (2023-2028) & (M Units)
    Table 64. Europe Functional Dyspepsia Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Functional Dyspepsia Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Functional Dyspepsia Drug Sales by Country (2017-2022) & (M Units)
    Table 67. Europe Functional Dyspepsia Drug Sales by Country (2023-2028) & (M Units)
    Table 68. Europe Functional Dyspepsia Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Functional Dyspepsia Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Functional Dyspepsia Drug Sales by Type (2017-2022) & (M Units)
    Table 71. Asia Pacific Functional Dyspepsia Drug Sales by Type (2023-2028) & (M Units)
    Table 72. Asia Pacific Functional Dyspepsia Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Functional Dyspepsia Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Functional Dyspepsia Drug Sales by Application (2017-2022) & (M Units)
    Table 75. Asia Pacific Functional Dyspepsia Drug Sales by Application (2023-2028) & (M Units)
    Table 76. Asia Pacific Functional Dyspepsia Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Functional Dyspepsia Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Functional Dyspepsia Drug Sales by Region (2017-2022) & (M Units)
    Table 79. Asia Pacific Functional Dyspepsia Drug Sales by Region (2023-2028) & (M Units)
    Table 80. Asia Pacific Functional Dyspepsia Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Functional Dyspepsia Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Functional Dyspepsia Drug Sales by Type (2017-2022) & (M Units)
    Table 83. Latin America Functional Dyspepsia Drug Sales by Type (2023-2028) & (M Units)
    Table 84. Latin America Functional Dyspepsia Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Functional Dyspepsia Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Functional Dyspepsia Drug Sales by Application (2017-2022) & (M Units)
    Table 87. Latin America Functional Dyspepsia Drug Sales by Application (2023-2028) & (M Units)
    Table 88. Latin America Functional Dyspepsia Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Functional Dyspepsia Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Functional Dyspepsia Drug Sales by Country (2017-2022) & (M Units)
    Table 91. Latin America Functional Dyspepsia Drug Sales by Country (2023-2028) & (M Units)
    Table 92. Latin America Functional Dyspepsia Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Functional Dyspepsia Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Functional Dyspepsia Drug Sales by Type (2017-2022) & (M Units)
    Table 95. Middle East and Africa Functional Dyspepsia Drug Sales by Type (2023-2028) & (M Units)
    Table 96. Middle East and Africa Functional Dyspepsia Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Functional Dyspepsia Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Functional Dyspepsia Drug Sales by Application (2017-2022) & (M Units)
    Table 99. Middle East and Africa Functional Dyspepsia Drug Sales by Application (2023-2028) & (M Units)
    Table 100. Middle East and Africa Functional Dyspepsia Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Functional Dyspepsia Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Functional Dyspepsia Drug Sales by Country (2017-2022) & (M Units)
    Table 103. Middle East and Africa Functional Dyspepsia Drug Sales by Country (2023-2028) & (M Units)
    Table 104. Middle East and Africa Functional Dyspepsia Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Functional Dyspepsia Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Bayer Corporation Information
    Table 107. Bayer Description and Major Businesses
    Table 108. Bayer Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 109. Bayer Functional Dyspepsia Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Bayer Recent Developments
    Table 111. Sumitomo Corporation Information
    Table 112. Sumitomo Description and Major Businesses
    Table 113. Sumitomo Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 114. Sumitomo Functional Dyspepsia Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Sumitomo Recent Developments
    Table 116. Cadila Pharmaceuticals Corporation Information
    Table 117. Cadila Pharmaceuticals Description and Major Businesses
    Table 118. Cadila Pharmaceuticals Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 119. Cadila Pharmaceuticals Functional Dyspepsia Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Cadila Pharmaceuticals Recent Developments
    Table 121. Teva Corporation Information
    Table 122. Teva Description and Major Businesses
    Table 123. Teva Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 124. Teva Functional Dyspepsia Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Teva Recent Developments
    Table 126. Johnson & Johnson Corporation Information
    Table 127. Johnson & Johnson Description and Major Businesses
    Table 128. Johnson & Johnson Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 129. Johnson & Johnson Functional Dyspepsia Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Johnson & Johnson Recent Developments
    Table 131. Pfizer Corporation Information
    Table 132. Pfizer Description and Major Businesses
    Table 133. Pfizer Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 134. Pfizer Functional Dyspepsia Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Pfizer Recent Developments
    Table 136. Sanofi Corporation Information
    Table 137. Sanofi Description and Major Businesses
    Table 138. Sanofi Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 139. Sanofi Functional Dyspepsia Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Sanofi Recent Developments
    Table 141. AstraZeneca Corporation Information
    Table 142. AstraZeneca Description and Major Businesses
    Table 143. AstraZeneca Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 144. AstraZeneca Functional Dyspepsia Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. AstraZeneca Recent Developments
    Table 146. Jiangsu Aosaikang Pharma Corporation Information
    Table 147. Jiangsu Aosaikang Pharma Description and Major Businesses
    Table 148. Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 149. Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. Jiangsu Aosaikang Pharma Recent Developments
    Table 151. Eisai Corporation Information
    Table 152. Eisai Description and Major Businesses
    Table 153. Eisai Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 154. Eisai Functional Dyspepsia Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 155. Eisai Recent Developments
    Table 156. Kyowa Kirin Pharmaceuticals Corporation Information
    Table 157. Kyowa Kirin Pharmaceuticals Description and Major Businesses
    Table 158. Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 159. Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 160. Kyowa Kirin Pharmaceuticals Recent Developments
    Table 161. Hanmi Pharm Corporation Information
    Table 162. Hanmi Pharm Description and Major Businesses
    Table 163. Hanmi Pharm Functional Dyspepsia Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 164. Hanmi Pharm Functional Dyspepsia Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 165. Hanmi Pharm Recent Developments
    Table 166. Key Raw Materials Lists
    Table 167. Raw Materials Key Suppliers Lists
    Table 168. Functional Dyspepsia Drug Distributors List
    Table 169. Functional Dyspepsia Drug Customers List
    Table 170. Functional Dyspepsia Drug Market Trends
    Table 171. Functional Dyspepsia Drug Market Drivers
    Table 172. Functional Dyspepsia Drug Market Challenges
    Table 173. Functional Dyspepsia Drug Market Restraints
    Table 174. Research Programs/Design for This Report
    Table 175. Key Data Information from Secondary Sources
    Table 176. Key Data Information from Primary Sources
List of Figures
    Figure 1. Functional Dyspepsia Drug Product Picture
    Figure 3. Global Functional Dyspepsia Drug Market Share by Type in 2021 & 2028
    Figure 3. Prokinetic Drugs Product Picture
    Figure 4. Gastric Antisecretory Drugs Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Functional Dyspepsia Drug Market Share by Application in 2021 & 2028
    Figure 7. Hospitals
    Figure 8. Drugstores
    Figure 9. Functional Dyspepsia Drug Report Years Considered
    Figure 10. Global Functional Dyspepsia Drug Sales 2017-2028 (M Units)
    Figure 11. Global Functional Dyspepsia Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Functional Dyspepsia Drug Revenue 2017-2028 (US$ Million)
    Figure 13. Global Functional Dyspepsia Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Functional Dyspepsia Drug Sales Market Share by Region (2017-2022)
    Figure 15. Global Functional Dyspepsia Drug Sales Market Share by Region (2023-2028)
    Figure 16. North America Functional Dyspepsia Drug Sales YoY (2017-2028) & (M Units)
    Figure 17. North America Functional Dyspepsia Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Functional Dyspepsia Drug Sales YoY (2017-2028) & (M Units)
    Figure 19. Europe Functional Dyspepsia Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Functional Dyspepsia Drug Sales YoY (2017-2028) & (M Units)
    Figure 21. Asia-Pacific Functional Dyspepsia Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Functional Dyspepsia Drug Sales YoY (2017-2028) & (M Units)
    Figure 23. Latin America Functional Dyspepsia Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Functional Dyspepsia Drug Sales YoY (2017-2028) & (M Units)
    Figure 25. Middle East & Africa Functional Dyspepsia Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Functional Dyspepsia Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Functional Dyspepsia Drug in the World: Market Share by Functional Dyspepsia Drug Revenue in 2021
    Figure 28. Global Functional Dyspepsia Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Functional Dyspepsia Drug Sales Market Share by Type (2017-2028)
    Figure 30. Global Functional Dyspepsia Drug Revenue Market Share by Type (2017-2028)
    Figure 31. Global Functional Dyspepsia Drug Sales Market Share by Application (2017-2028)
    Figure 32. Global Functional Dyspepsia Drug Revenue Market Share by Application (2017-2028)
    Figure 33. North America Functional Dyspepsia Drug Sales Market Share by Type (2017-2028)
    Figure 34. North America Functional Dyspepsia Drug Revenue Market Share by Type (2017-2028)
    Figure 35. North America Functional Dyspepsia Drug Sales Market Share by Application (2017-2028)
    Figure 36. North America Functional Dyspepsia Drug Revenue Market Share by Application (2017-2028)
    Figure 37. North America Functional Dyspepsia Drug Sales Share by Country (2017-2028)
    Figure 38. North America Functional Dyspepsia Drug Revenue Share by Country (2017-2028)
    Figure 39. U.S. Functional Dyspepsia Drug Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Functional Dyspepsia Drug Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Functional Dyspepsia Drug Sales Market Share by Type (2017-2028)
    Figure 42. Europe Functional Dyspepsia Drug Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Functional Dyspepsia Drug Sales Market Share by Application (2017-2028)
    Figure 44. Europe Functional Dyspepsia Drug Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Functional Dyspepsia Drug Sales Share by Country (2017-2028)
    Figure 46. Europe Functional Dyspepsia Drug Revenue Share by Country (2017-2028)
    Figure 47. Germany Functional Dyspepsia Drug Revenue (2017-2028) & (US$ Million)
    Figure 48. France Functional Dyspepsia Drug Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Functional Dyspepsia Drug Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Functional Dyspepsia Drug Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Functional Dyspepsia Drug Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Functional Dyspepsia Drug Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Functional Dyspepsia Drug Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Functional Dyspepsia Drug Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Functional Dyspepsia Drug Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Functional Dyspepsia Drug Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Functional Dyspepsia Drug Revenue Share by Region (2017-2028)
    Figure 58. China Functional Dyspepsia Drug Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Functional Dyspepsia Drug Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Functional Dyspepsia Drug Revenue (2017-2028) & (US$ Million)
    Figure 61. India Functional Dyspepsia Drug Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Functional Dyspepsia Drug Revenue (2017-2028) & (US$ Million)
    Figure 63. Taiwan Functional Dyspepsia Drug Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Functional Dyspepsia Drug Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Functional Dyspepsia Drug Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Functional Dyspepsia Drug Revenue (2017-2028) & (US$ Million)
    Figure 67. Philippines Functional Dyspepsia Drug Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Functional Dyspepsia Drug Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Functional Dyspepsia Drug Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Functional Dyspepsia Drug Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Functional Dyspepsia Drug Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Functional Dyspepsia Drug Sales Share by Country (2017-2028)
    Figure 73. Latin America Functional Dyspepsia Drug Revenue Share by Country (2017-2028)
    Figure 74. Mexico Functional Dyspepsia Drug Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Functional Dyspepsia Drug Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Functional Dyspepsia Drug Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Functional Dyspepsia Drug Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Functional Dyspepsia Drug Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Functional Dyspepsia Drug Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Functional Dyspepsia Drug Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Functional Dyspepsia Drug Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Functional Dyspepsia Drug Revenue Share by Country (2017-2028)
    Figure 83. Turkey Functional Dyspepsia Drug Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Functional Dyspepsia Drug Revenue (2017-2028) & (US$ Million)
    Figure 85. UAE Functional Dyspepsia Drug Revenue (2017-2028) & (US$ Million)
    Figure 86. Functional Dyspepsia Drug Value Chain
    Figure 87. Functional Dyspepsia Drug Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bayer
Sumitomo
Cadila Pharmaceuticals
Teva
Johnson & Johnson
Pfizer
Sanofi
AstraZeneca
Jiangsu Aosaikang Pharma
Eisai
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
Frequently Asked Questions
Functional Dyspepsia Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Functional Dyspepsia Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Functional Dyspepsia Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports